Immunotherapy
Calidi Biotherapeutics Inc. Advances Oncology Pipeline and Strategic Goals in 2025
Calidi Biotherapeutics Inc. outlines significant progress in its oncology immunotherapy pipeline and strategic initiatives aimed at enhancing shareholder value and advancing cancer treatment options.
Fermented Wheat Germ Could Enhance Immunotherapy Outcomes for Cancer Patients
A clinical trial at UC Davis is exploring the potential of fermented wheat germ to improve immunotherapy results for cancer patients, offering hope for better survival rates and quality of life.
Electric Fields Found to Enhance Immune Response Against Glioblastoma
A recent study by the University of Southern California reveals that electric fields can significantly boost the immune system's fight against glioblastoma, offering hope for extended patient survival and new treatment avenues.
Lifordi Immunotherapeutics Unveils Promising Preclinical Data for LFD-200 at EULAR 2025
Lifordi Immunotherapeutics has presented preclinical data on LFD-200, a novel antibody-drug conjugate targeting autoimmune and inflammatory diseases, showing efficacy without systemic toxicity, marking a potential breakthrough in treatment options.
Calidi Biotherapeutics Unveils Promising Data on CLD-401 at ASCO 2025
Calidi Biotherapeutics Inc. presents groundbreaking data on its lead candidate CLD-401 at the ASCO Annual Meeting, showcasing advancements in systemic oncolytic targeted immunotherapies with potential implications for cancer treatment.
Korean Researchers Develop AI Model to Enhance Cancer Immunotherapy Precision
A South Korean research team has created an innovative AI model capable of predicting patient responses to immunotherapy for colorectal and gastric cancers, potentially revolutionizing personalized cancer treatment strategies.
University of Houston Receives $3M Grant to Advance Cancer Immunotherapy Research
The Texas Cancer Prevention & Research Institute awarded the University of Houston $3 million to establish a biomarker core, potentially transforming cancer research and patient outcomes through advanced immunotherapy techniques.
Creative Biolabs Unveils Advanced Bispecific Antibody Platform at Industry Conference
Creative Biolabs demonstrates cutting-edge bispecific antibody technology with potential to revolutionize cancer immunotherapy, showcasing customized development capabilities and innovative research approaches.
Calidi Biotherapeutics Advances Cancer Immunotherapy Platform, Reduces Quarterly Losses
Calidi Biotherapeutics has made significant progress in its oncology research, receiving FDA clearance for a stem cell-based immunotherapy and presenting promising data on its Redtail virotherapy platform while simultaneously reducing operational expenses.
Calidi Biotherapeutics Advances Cancer Treatment Platform with Innovative Immunotherapy Approach
Calidi Biotherapeutics has developed a novel systemic antitumor virotherapy platform that delivers an IL15 superagonist directly into tumor microenvironments, potentially revolutionizing metastatic cancer treatment by boosting immune response while minimizing systemic toxicity.
Creative Biolabs Advances Antibody Technologies to Revolutionize Cancer Treatment
Creative Biolabs is expanding its innovative antibody-related technologies, targeting critical advancements in cancer research and immunotherapy. The company's platforms aim to enhance drug delivery precision and improve therapeutic strategies for previously challenging medical conditions.
Portuguese Researchers Uncover Promising Immunotherapy Approach for Colorectal Cancer
A breakthrough discovery by Portuguese researchers reveals a new type of white blood cell with exceptional tumor identification capabilities, potentially revolutionizing colorectal cancer treatment through targeted immunotherapy.
Portuguese Researchers Uncover Promising White Blood Cell for Colorectal Cancer Immunotherapy
Researchers in Portugal have identified a novel white blood cell type with potent tumor cell identification capabilities, potentially revolutionizing immunotherapy approaches for colorectal cancer, the third most common cancer globally.